Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2023 | 382 | 1.580 |
Why?
|
| Neoplasm, Residual | 1 | 2020 | 1008 | 0.500 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 768 | 0.430 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 2824 | 0.330 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2005 | 3769 | 0.270 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 1551 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11740 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 314 | 0.170 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 146 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2021 | 2985 | 0.160 |
Why?
|
| Remission Induction | 2 | 2023 | 2395 | 0.150 |
Why?
|
| Prostate | 1 | 2005 | 1770 | 0.140 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 857 | 0.130 |
Why?
|
| Wilms Tumor | 1 | 2019 | 379 | 0.130 |
Why?
|
| Mutation | 3 | 2022 | 30045 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2018 | 23441 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 805 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 1222 | 0.100 |
Why?
|
| Apoptosis | 3 | 2022 | 9488 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2020 | 42254 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.080 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10194 | 0.070 |
Why?
|
| Child | 6 | 2023 | 80162 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5305 | 0.070 |
Why?
|
| Zebrafish | 1 | 2018 | 3007 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3612 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 12720 | 0.070 |
Why?
|
| Prostatic Neoplasms | 2 | 2005 | 11118 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5670 | 0.060 |
Why?
|
| Algorithms | 1 | 2005 | 14026 | 0.060 |
Why?
|
| Spin Labels | 1 | 2005 | 337 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10203 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4248 | 0.050 |
Why?
|
| Adolescent | 3 | 2020 | 88313 | 0.050 |
Why?
|
| Janus Kinase 3 | 1 | 2022 | 76 | 0.050 |
Why?
|
| Infant | 2 | 2020 | 36205 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9277 | 0.050 |
Why?
|
| Epithelium | 1 | 2004 | 1603 | 0.040 |
Why?
|
| Protons | 1 | 2005 | 1115 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29620 | 0.040 |
Why?
|
| Male | 8 | 2020 | 360736 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17912 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39117 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16979 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2021 | 863 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 550 | 0.040 |
Why?
|
| Young Adult | 2 | 2023 | 59207 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 337 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 695 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 479 | 0.040 |
Why?
|
| Humans | 11 | 2023 | 761423 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2019 | 601 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 1693 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 764 | 0.030 |
Why?
|
| Mitochondria | 2 | 2019 | 3623 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 80582 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1405 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 1079 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2019 | 937 | 0.030 |
Why?
|
| Female | 4 | 2020 | 392581 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 6814 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2161 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1858 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2020 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2831 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4278 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14664 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 221148 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4124 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 168441 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4741 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8999 | 0.020 |
Why?
|
| Genome, Human | 1 | 2021 | 4425 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 20093 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3845 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7595 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7049 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22168 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41446 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13637 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 2469 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81509 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11106 | 0.010 |
Why?
|
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_